

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.80868035 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.53188485 |
| 3 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.42916385 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.39072298 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08081383 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.96288893 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.96288893 |
| 8 | signal peptide processing (GO:0006465) | 4.94803399 |
| 9 | DNA deamination (GO:0045006) | 4.75518768 |
| 10 | respiratory electron transport chain (GO:0022904) | 4.70564151 |
| 11 | proteasome assembly (GO:0043248) | 4.65005316 |
| 12 | electron transport chain (GO:0022900) | 4.63024324 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 4.60173805 |
| 14 | protein neddylation (GO:0045116) | 4.27873527 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20930593 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.20930593 |
| 17 | platelet dense granule organization (GO:0060155) | 4.20609899 |
| 18 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.07706955 |
| 19 | response to interferon-beta (GO:0035456) | 4.07152861 |
| 20 | polyketide metabolic process (GO:0030638) | 4.01106149 |
| 21 | doxorubicin metabolic process (GO:0044598) | 4.01106149 |
| 22 | daunorubicin metabolic process (GO:0044597) | 4.01106149 |
| 23 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72325180 |
| 24 | endosome to pigment granule transport (GO:0043485) | 3.71647977 |
| 25 | endosome to melanosome transport (GO:0035646) | 3.71647977 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66489499 |
| 27 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.62660004 |
| 28 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.61180613 |
| 29 | termination of RNA polymerase III transcription (GO:0006386) | 3.61180613 |
| 30 | cullin deneddylation (GO:0010388) | 3.54222513 |
| 31 | respiratory chain complex IV assembly (GO:0008535) | 3.36407776 |
| 32 | defense response to protozoan (GO:0042832) | 3.33076559 |
| 33 | peptidyl-histidine modification (GO:0018202) | 3.32074522 |
| 34 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.29330899 |
| 35 | definitive hemopoiesis (GO:0060216) | 3.26563402 |
| 36 | protein targeting to mitochondrion (GO:0006626) | 3.25150398 |
| 37 | protein deneddylation (GO:0000338) | 3.23203175 |
| 38 | protein-cofactor linkage (GO:0018065) | 3.20296714 |
| 39 | cotranslational protein targeting to membrane (GO:0006613) | 3.20003510 |
| 40 | cytochrome complex assembly (GO:0017004) | 3.19851759 |
| 41 | protein localization to mitochondrion (GO:0070585) | 3.19014025 |
| 42 | protein targeting to ER (GO:0045047) | 3.16049532 |
| 43 | establishment of protein localization to mitochondrion (GO:0072655) | 3.14400286 |
| 44 | hydrogen ion transmembrane transport (GO:1902600) | 3.13533505 |
| 45 | response to protozoan (GO:0001562) | 3.09368194 |
| 46 | protein localization to endoplasmic reticulum (GO:0070972) | 3.08670300 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.07704771 |
| 48 | cellular response to interferon-beta (GO:0035458) | 3.01535563 |
| 49 | purine-containing compound salvage (GO:0043101) | 3.01400208 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.99191500 |
| 51 | regulation of hexokinase activity (GO:1903299) | 2.98915215 |
| 52 | regulation of glucokinase activity (GO:0033131) | 2.98915215 |
| 53 | inner mitochondrial membrane organization (GO:0007007) | 2.97140734 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.95155052 |
| 55 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94420376 |
| 56 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93437002 |
| 57 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92712409 |
| 58 | proton transport (GO:0015992) | 2.91346450 |
| 59 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.91001200 |
| 60 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.91001200 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 2.90710730 |
| 62 | mast cell activation (GO:0045576) | 2.90678292 |
| 63 | organelle disassembly (GO:1903008) | 2.90480194 |
| 64 | rRNA modification (GO:0000154) | 2.89196589 |
| 65 | intracellular protein transmembrane import (GO:0044743) | 2.88734395 |
| 66 | behavioral response to nicotine (GO:0035095) | 2.88503994 |
| 67 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88446298 |
| 68 | DNA double-strand break processing (GO:0000729) | 2.88343916 |
| 69 | ATP biosynthetic process (GO:0006754) | 2.85977309 |
| 70 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.85851091 |
| 71 | hydrogen transport (GO:0006818) | 2.85296945 |
| 72 | lymphoid progenitor cell differentiation (GO:0002320) | 2.83602895 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.82635098 |
| 74 | metallo-sulfur cluster assembly (GO:0031163) | 2.82347775 |
| 75 | iron-sulfur cluster assembly (GO:0016226) | 2.82347775 |
| 76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82323248 |
| 77 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.81570862 |
| 78 | viral transcription (GO:0019083) | 2.79635140 |
| 79 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.79627073 |
| 80 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.75645662 |
| 81 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.73925364 |
| 82 | cellular response to exogenous dsRNA (GO:0071360) | 2.72198358 |
| 83 | mitochondrial transport (GO:0006839) | 2.71811693 |
| 84 | translational termination (GO:0006415) | 2.71323252 |
| 85 | toxin transport (GO:1901998) | 2.71088424 |
| 86 | negative regulation of phagocytosis (GO:0050765) | 2.70214559 |
| 87 | pseudouridine synthesis (GO:0001522) | 2.68698694 |
| 88 | ribonucleoprotein complex disassembly (GO:0032988) | 2.67186287 |
| 89 | valine metabolic process (GO:0006573) | 2.65619074 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63899726 |
| 91 | DNA damage response, detection of DNA damage (GO:0042769) | 2.63376136 |
| 92 | protein complex biogenesis (GO:0070271) | 2.63329436 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.62634449 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.60302537 |
| 95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58075739 |
| 96 | mannosylation (GO:0097502) | 2.57820437 |
| 97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.57665224 |
| 98 | negative regulation of ligase activity (GO:0051352) | 2.57665224 |
| 99 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.57560369 |
| 100 | maturation of 5.8S rRNA (GO:0000460) | 2.57057380 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.56997067 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.56997067 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 2.56872436 |
| 104 | chromatin remodeling at centromere (GO:0031055) | 2.56366211 |
| 105 | response to type I interferon (GO:0034340) | 2.56211118 |
| 106 | response to interferon-alpha (GO:0035455) | 2.55935529 |
| 107 | CENP-A containing nucleosome assembly (GO:0034080) | 2.54962152 |
| 108 | glycoside metabolic process (GO:0016137) | 2.51746635 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51057393 |
| 110 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.50355662 |
| 111 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.50191826 |
| 112 | secretory granule organization (GO:0033363) | 2.50097462 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 2.49327533 |
| 114 | rRNA methylation (GO:0031167) | 2.49129986 |
| 115 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.48921343 |
| 116 | negative regulation of viral genome replication (GO:0045071) | 2.48511906 |
| 117 | translation (GO:0006412) | 2.47873083 |
| 118 | protein K6-linked ubiquitination (GO:0085020) | 2.47303994 |
| 119 | cellular ketone body metabolic process (GO:0046950) | 2.46370761 |
| 120 | response to peptidoglycan (GO:0032494) | 2.46121897 |
| 121 | L-fucose catabolic process (GO:0042355) | 2.45890849 |
| 122 | fucose catabolic process (GO:0019317) | 2.45890849 |
| 123 | L-fucose metabolic process (GO:0042354) | 2.45890849 |
| 124 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.45482928 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.45298418 |
| 126 | anterograde synaptic vesicle transport (GO:0048490) | 2.45262815 |
| 127 | cellular component biogenesis (GO:0044085) | 2.44051958 |
| 128 | regulation of mitochondrial translation (GO:0070129) | 2.43676699 |
| 129 | GTP biosynthetic process (GO:0006183) | 2.42928779 |
| 130 | translational elongation (GO:0006414) | 2.42837872 |
| 131 | detection of bacterium (GO:0016045) | 2.42734082 |
| 132 | megakaryocyte development (GO:0035855) | 2.42297367 |
| 133 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.41704566 |
| 134 | dopamine transport (GO:0015872) | 2.40846706 |
| 135 | detection of other organism (GO:0098543) | 2.40661300 |
| 136 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40656760 |
| 137 | response to redox state (GO:0051775) | 2.40373813 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.39904109 |
| 139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.39904109 |
| 140 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.39904109 |
| 141 | tRNA processing (GO:0008033) | 2.39618875 |
| 142 | necroptotic process (GO:0070266) | 2.39428923 |
| 143 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.39312793 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.38907748 |
| 145 | resolution of meiotic recombination intermediates (GO:0000712) | 2.38741790 |
| 146 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.37727045 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.37218465 |
| 148 | respiratory burst (GO:0045730) | 2.36862270 |
| 149 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.36434004 |
| 150 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.36434004 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.36005218 |
| 152 | 7-methylguanosine mRNA capping (GO:0006370) | 2.35793280 |
| 153 | positive regulation of ligase activity (GO:0051351) | 2.35138653 |
| 154 | ubiquinone biosynthetic process (GO:0006744) | 2.34742034 |
| 155 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.33783512 |
| 156 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.33783512 |
| 157 | NADH dehydrogenase complex assembly (GO:0010257) | 2.33783512 |
| 158 | transcription from mitochondrial promoter (GO:0006390) | 2.32959569 |
| 159 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.32049281 |
| 160 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.32033174 |
| 161 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.31796016 |
| 162 | ubiquinone metabolic process (GO:0006743) | 2.31447959 |
| 163 | nonmotile primary cilium assembly (GO:0035058) | 2.30851566 |
| 164 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.30608716 |
| 165 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30423730 |
| 166 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.29939944 |
| 167 | 7-methylguanosine RNA capping (GO:0009452) | 2.29493963 |
| 168 | RNA capping (GO:0036260) | 2.29493963 |
| 169 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.28874799 |
| 170 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.27223763 |
| 171 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.27223763 |
| 172 | ribosomal small subunit biogenesis (GO:0042274) | 2.27143898 |
| 173 | intracellular protein transmembrane transport (GO:0065002) | 2.26975112 |
| 174 | L-methionine biosynthetic process (GO:0071265) | 2.26435904 |
| 175 | amino acid salvage (GO:0043102) | 2.26435904 |
| 176 | T cell lineage commitment (GO:0002360) | 2.26419554 |
| 177 | aerobic respiration (GO:0009060) | 2.24311469 |
| 178 | telomere maintenance via recombination (GO:0000722) | 2.22869563 |
| 179 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.21949140 |
| 180 | regulation of RIG-I signaling pathway (GO:0039535) | 2.20678426 |
| 181 | leukocyte degranulation (GO:0043299) | 2.19957972 |
| 182 | positive regulation of macrophage differentiation (GO:0045651) | 2.17562133 |
| 183 | viral life cycle (GO:0019058) | 2.15928367 |
| 184 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.15764011 |
| 185 | reactive oxygen species biosynthetic process (GO:1903409) | 2.14197754 |
| 186 | oxidative phosphorylation (GO:0006119) | 2.13205792 |
| 187 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.12763457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40777535 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.82904988 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.63058981 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.48688902 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.14950134 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.13502987 |
| 7 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.99839264 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.91001374 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88717032 |
| 10 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.83996528 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81866758 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.78861906 |
| 13 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.72313886 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57188286 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47524519 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42687450 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.42258016 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40284625 |
| 19 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.37392285 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.36970740 |
| 21 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.34696443 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33504030 |
| 23 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31451226 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.30640510 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.25668833 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.23098749 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19680216 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18575367 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16881760 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16679982 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.09487391 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07990274 |
| 33 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.07942402 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06919693 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.06381967 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05586929 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04628288 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.01177218 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.00781398 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00268801 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98888932 |
| 42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98246771 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.98160232 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96073578 |
| 45 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94853248 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.94664448 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90702714 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89137504 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88845655 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88540315 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.88391009 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88131115 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87564536 |
| 54 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86487918 |
| 55 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85998576 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81717756 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81312839 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75859242 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75331338 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73568140 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.72468279 |
| 62 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.69102241 |
| 63 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.68460533 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66934961 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66074955 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61935296 |
| 67 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60335463 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59615277 |
| 69 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58321822 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.58255040 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.57061327 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54484817 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54132448 |
| 74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52852507 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51467379 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51362118 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49295149 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48622183 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47614543 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47174878 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45241340 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43469396 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40952025 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.40912421 |
| 85 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.38780468 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36268422 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35811447 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.35640739 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35063804 |
| 90 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34126924 |
| 91 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33743248 |
| 92 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33455914 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31706537 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30143572 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25611043 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25593783 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25295697 |
| 98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.24864639 |
| 99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23822795 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22938510 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21555404 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21290861 |
| 103 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21118078 |
| 104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21077118 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19815828 |
| 106 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.19737070 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 1.18441420 |
| 108 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17504181 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17206765 |
| 110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16517558 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15614026 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14399079 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14009908 |
| 114 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13148572 |
| 115 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12442545 |
| 116 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12311459 |
| 117 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.12296565 |
| 118 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11868265 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09302557 |
| 120 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09177918 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08888382 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08021607 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07298390 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06375789 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05226480 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05031787 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04998861 |
| 128 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04385945 |
| 129 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04385945 |
| 130 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.04032766 |
| 131 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03404915 |
| 132 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03088169 |
| 133 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03042889 |
| 134 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03042889 |
| 135 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02398593 |
| 136 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02148312 |
| 137 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01970289 |
| 138 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.01605003 |
| 139 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01362018 |
| 140 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01251040 |
| 141 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01243265 |
| 142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00868704 |
| 143 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00063206 |
| 144 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99735629 |
| 145 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99559038 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99480638 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99202788 |
| 148 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99129209 |
| 149 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98665433 |
| 150 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97559678 |
| 151 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96123138 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96074704 |
| 153 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95865790 |
| 154 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95865790 |
| 155 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95687564 |
| 156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95613797 |
| 157 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95433339 |
| 158 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95286205 |
| 159 | MAF_26560356_Chip-Seq_TH1_Human | 0.94580996 |
| 160 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93684720 |
| 161 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93382506 |
| 162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93198145 |
| 163 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93139015 |
| 164 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92561515 |
| 165 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91810883 |
| 166 | MYC_22102868_ChIP-Seq_BL_Human | 0.91744897 |
| 167 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90535654 |
| 168 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89977271 |
| 169 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.87988218 |
| 170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87621526 |
| 171 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87185392 |
| 172 | JUN_21703547_ChIP-Seq_K562_Human | 0.86028694 |
| 173 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85771289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.86839723 |
| 2 | MP0009785_altered_susceptibility_to | 3.10744432 |
| 3 | MP0005671_abnormal_response_to | 2.93261717 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.91699265 |
| 5 | MP0003724_increased_susceptibility_to | 2.70221305 |
| 6 | MP0001529_abnormal_vocalization | 2.62499588 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.61447529 |
| 8 | MP0000685_abnormal_immune_system | 2.52320547 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.48600690 |
| 10 | MP0003436_decreased_susceptibility_to | 2.38995885 |
| 11 | MP0005025_abnormal_response_to | 2.27794731 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.27442125 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.26905130 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.17466891 |
| 15 | MP0004147_increased_porphyrin_level | 2.16993828 |
| 16 | MP0001853_heart_inflammation | 2.13309508 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.11651167 |
| 18 | MP0002419_abnormal_innate_immunity | 2.11521253 |
| 19 | MP0002938_white_spotting | 2.06607696 |
| 20 | MP0003880_abnormal_central_pattern | 2.05667460 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 2.05589486 |
| 22 | MP0002102_abnormal_ear_morphology | 2.03554186 |
| 23 | MP0001800_abnormal_humoral_immune | 2.02305453 |
| 24 | MP0002723_abnormal_immune_serum | 1.97695248 |
| 25 | MP0005387_immune_system_phenotype | 1.95803910 |
| 26 | MP0001790_abnormal_immune_system | 1.95803910 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.95460453 |
| 28 | MP0003186_abnormal_redox_activity | 1.94414503 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.93276748 |
| 30 | MP0001984_abnormal_olfaction | 1.92395923 |
| 31 | MP0009046_muscle_twitch | 1.92067913 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.90109288 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.88983918 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.87917583 |
| 35 | MP0001819_abnormal_immune_cell | 1.87646863 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.84293657 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.78237583 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.78026009 |
| 39 | MP0002163_abnormal_gland_morphology | 1.76722892 |
| 40 | MP0002398_abnormal_bone_marrow | 1.70385606 |
| 41 | MP0001873_stomach_inflammation | 1.70151727 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.69249937 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.68802828 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.68802828 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.66998163 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.65105867 |
| 47 | MP0001764_abnormal_homeostasis | 1.64426530 |
| 48 | MP0003718_maternal_effect | 1.63446002 |
| 49 | MP0002736_abnormal_nociception_after | 1.63184651 |
| 50 | MP0003787_abnormal_imprinting | 1.62698339 |
| 51 | MP0005365_abnormal_bile_salt | 1.62118497 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.61018972 |
| 53 | MP0003122_maternal_imprinting | 1.59052631 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.59015279 |
| 55 | MP0008469_abnormal_protein_level | 1.57502657 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.57366711 |
| 57 | MP0000716_abnormal_immune_system | 1.56713113 |
| 58 | MP0003121_genomic_imprinting | 1.54607756 |
| 59 | MP0003866_abnormal_defecation | 1.54476954 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.54087928 |
| 61 | MP0009697_abnormal_copulation | 1.53863393 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.53825313 |
| 63 | MP0002132_abnormal_respiratory_system | 1.50641630 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.50461487 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.50348375 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.50290799 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.50149907 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.48246898 |
| 69 | MP0009745_abnormal_behavioral_response | 1.47944257 |
| 70 | MP0002006_tumorigenesis | 1.47356644 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47163940 |
| 72 | * MP0001905_abnormal_dopamine_level | 1.46626066 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.46264425 |
| 74 | MP0009764_decreased_sensitivity_to | 1.45818311 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.45179501 |
| 76 | MP0004133_heterotaxia | 1.43899170 |
| 77 | MP0006054_spinal_hemorrhage | 1.42691971 |
| 78 | MP0002272_abnormal_nervous_system | 1.42045823 |
| 79 | MP0002429_abnormal_blood_cell | 1.41524572 |
| 80 | MP0000490_abnormal_crypts_of | 1.40027344 |
| 81 | MP0001968_abnormal_touch/_nociception | 1.39398841 |
| 82 | MP0002722_abnormal_immune_system | 1.38910156 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.38681915 |
| 84 | MP0002405_respiratory_system_inflammati | 1.38533401 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.37287832 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 1.36405107 |
| 87 | MP0002160_abnormal_reproductive_system | 1.35968324 |
| 88 | * MP0004142_abnormal_muscle_tone | 1.35064567 |
| 89 | MP0006292_abnormal_olfactory_placode | 1.33720832 |
| 90 | MP0002876_abnormal_thyroid_physiology | 1.32854188 |
| 91 | MP0004215_abnormal_myocardial_fiber | 1.32163030 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.31798307 |
| 93 | MP0002638_abnormal_pupillary_reflex | 1.31271306 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 1.29721267 |
| 95 | MP0005253_abnormal_eye_physiology | 1.28491230 |
| 96 | MP0003123_paternal_imprinting | 1.26489727 |
| 97 | MP0000569_abnormal_digit_pigmentation | 1.25495183 |
| 98 | MP0002693_abnormal_pancreas_physiology | 1.24463560 |
| 99 | MP0005085_abnormal_gallbladder_physiolo | 1.24424050 |
| 100 | MP0008789_abnormal_olfactory_epithelium | 1.24229673 |
| 101 | MP0003941_abnormal_skin_development | 1.23528702 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 1.23157096 |
| 103 | MP0003786_premature_aging | 1.22592373 |
| 104 | MP0001188_hyperpigmentation | 1.22168930 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 1.21214223 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 1.20780089 |
| 107 | MP0002090_abnormal_vision | 1.20431427 |
| 108 | MP0005408_hypopigmentation | 1.20142516 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 1.19779864 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 1.18680170 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 1.15498879 |
| 112 | MP0006082_CNS_inflammation | 1.15089472 |
| 113 | MP0004270_analgesia | 1.14828001 |
| 114 | MP0008995_early_reproductive_senescence | 1.12716067 |
| 115 | MP0000681_abnormal_thyroid_gland | 1.12438635 |
| 116 | MP0009643_abnormal_urine_homeostasis | 1.11527874 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 1.09338335 |
| 118 | MP0002184_abnormal_innervation | 1.08677535 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 1.08568499 |
| 120 | MP0005360_urolithiasis | 1.08395424 |
| 121 | MP0002822_catalepsy | 1.08374983 |
| 122 | MP0008007_abnormal_cellular_replicative | 1.07942722 |
| 123 | MP0008872_abnormal_physiological_respon | 1.07182500 |
| 124 | MP0005636_abnormal_mineral_homeostasis | 1.06515504 |
| 125 | MP0001533_abnormal_skeleton_physiology | 1.06177754 |
| 126 | MP0004924_abnormal_behavior | 1.04222932 |
| 127 | MP0005386_behavior/neurological_phenoty | 1.04222932 |
| 128 | MP0003195_calcinosis | 1.02993787 |
| 129 | * MP0005332_abnormal_amino_acid | 1.02394409 |
| 130 | MP0002557_abnormal_social/conspecific_i | 1.01578823 |
| 131 | MP0001486_abnormal_startle_reflex | 1.01138137 |
| 132 | MP0000516_abnormal_urinary_system | 1.01101451 |
| 133 | MP0005367_renal/urinary_system_phenotyp | 1.01101451 |
| 134 | MP0000343_altered_response_to | 1.00326611 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.99697861 |
| 136 | MP0002572_abnormal_emotion/affect_behav | 0.99682547 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.98666128 |
| 138 | MP0005389_reproductive_system_phenotype | 0.98611319 |
| 139 | MP0002064_seizures | 0.97710935 |
| 140 | MP0001485_abnormal_pinna_reflex | 0.96453774 |
| 141 | MP0000372_irregular_coat_pigmentation | 0.95998582 |
| 142 | MP0000015_abnormal_ear_pigmentation | 0.95868038 |
| 143 | MP0008058_abnormal_DNA_repair | 0.94319211 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.94173781 |
| 145 | MP0003011_delayed_dark_adaptation | 0.93235281 |
| 146 | MP0005646_abnormal_pituitary_gland | 0.92617880 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.92133609 |
| 148 | MP0009763_increased_sensitivity_to | 0.91683083 |
| 149 | MP0003693_abnormal_embryo_hatching | 0.91664244 |
| 150 | MP0001663_abnormal_digestive_system | 0.91046548 |
| 151 | MP0003868_abnormal_feces_composition | 0.90611270 |
| 152 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90065008 |
| 153 | MP0004957_abnormal_blastocyst_morpholog | 0.90029827 |
| 154 | MP0004742_abnormal_vestibular_system | 0.87586884 |
| 155 | MP0002138_abnormal_hepatobiliary_system | 0.86728974 |
| 156 | MP0000647_abnormal_sebaceous_gland | 0.86166274 |
| 157 | MP0000703_abnormal_thymus_morphology | 0.85822260 |
| 158 | * MP0005319_abnormal_enzyme/_coenzyme | 0.85707154 |
| 159 | MP0003283_abnormal_digestive_organ | 0.85580837 |
| 160 | MP0005187_abnormal_penis_morphology | 0.84892382 |
| 161 | MP0003137_abnormal_impulse_conducting | 0.84837395 |
| 162 | MP0003119_abnormal_digestive_system | 0.84319215 |
| 163 | MP0003172_abnormal_lysosome_physiology | 0.83877851 |
| 164 | MP0000858_altered_metastatic_potential | 0.83145293 |
| 165 | MP0001944_abnormal_pancreas_morphology | 0.83045252 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.82782878 |
| 167 | MP0004043_abnormal_pH_regulation | 0.81834881 |
| 168 | MP0004145_abnormal_muscle_electrophysio | 0.81772295 |
| 169 | MP0003635_abnormal_synaptic_transmissio | 0.81571262 |
| 170 | MP0000538_abnormal_urinary_bladder | 0.81266486 |
| 171 | MP0005195_abnormal_posterior_eye | 0.81000043 |
| 172 | MP0000427_abnormal_hair_cycle | 0.80988862 |
| 173 | * MP0002067_abnormal_sensory_capabilities | 0.80702883 |
| 174 | MP0000013_abnormal_adipose_tissue | 0.80042048 |
| 175 | MP0010329_abnormal_lipoprotein_level | 0.79666799 |
| 176 | MP0001293_anophthalmia | 0.78237746 |
| 177 | MP0002233_abnormal_nose_morphology | 0.77710810 |
| 178 | MP0000049_abnormal_middle_ear | 0.77536540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive macrocephaly (HP:0004481) | 4.77455530 |
| 2 | Increased hepatocellular lipid droplets (HP:0006565) | 4.07566939 |
| 3 | Generalized aminoaciduria (HP:0002909) | 3.82286524 |
| 4 | Aplastic anemia (HP:0001915) | 3.81851742 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.81074833 |
| 6 | Type I transferrin isoform profile (HP:0003642) | 3.74292848 |
| 7 | IgM deficiency (HP:0002850) | 3.62216361 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.55631638 |
| 9 | Cerebral edema (HP:0002181) | 3.47843216 |
| 10 | Thrombocytosis (HP:0001894) | 3.47102922 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.46652969 |
| 12 | Petechiae (HP:0000967) | 3.22177486 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.22152447 |
| 14 | Hypothermia (HP:0002045) | 3.17282329 |
| 15 | Hepatic necrosis (HP:0002605) | 3.14216357 |
| 16 | Myositis (HP:0100614) | 3.13276698 |
| 17 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.10309296 |
| 18 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.10309296 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 3.10309296 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.10309296 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.07601112 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.07601112 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.06885842 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.06885842 |
| 25 | Methylmalonic acidemia (HP:0002912) | 3.00793090 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.99583885 |
| 27 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.95807309 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 2.95807309 |
| 29 | Hyperalaninemia (HP:0003348) | 2.95807309 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.94316567 |
| 31 | Pancreatic cysts (HP:0001737) | 2.91802821 |
| 32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.75212702 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.74291291 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.74255096 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 2.74057721 |
| 36 | True hermaphroditism (HP:0010459) | 2.72624278 |
| 37 | Chronic otitis media (HP:0000389) | 2.70471904 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.69901961 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.68472490 |
| 40 | B lymphocytopenia (HP:0010976) | 2.68472490 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.68360340 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.63181662 |
| 43 | Medial flaring of the eyebrow (HP:0010747) | 2.62063895 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.56592992 |
| 45 | Respiratory failure (HP:0002878) | 2.56211022 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55054603 |
| 47 | Nephronophthisis (HP:0000090) | 2.51140386 |
| 48 | Abnormality of renal resorption (HP:0011038) | 2.50155843 |
| 49 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47627957 |
| 50 | Epistaxis (HP:0000421) | 2.46545532 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46397171 |
| 52 | Optic disc pallor (HP:0000543) | 2.44197228 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.41674276 |
| 54 | Exertional dyspnea (HP:0002875) | 2.40157279 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.39065668 |
| 56 | Exercise intolerance (HP:0003546) | 2.36262736 |
| 57 | Leukodystrophy (HP:0002415) | 2.35345008 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32777940 |
| 59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31690306 |
| 60 | Limb dystonia (HP:0002451) | 2.31248142 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.30725581 |
| 62 | Muscle fiber atrophy (HP:0100295) | 2.29611865 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.29162835 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.28732138 |
| 65 | Microvesicular hepatic steatosis (HP:0001414) | 2.27759460 |
| 66 | Beaking of vertebral bodies (HP:0004568) | 2.25657664 |
| 67 | Gait imbalance (HP:0002141) | 2.25583589 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22395857 |
| 69 | Lethargy (HP:0001254) | 2.20222467 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.19762197 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.19336036 |
| 72 | Renal cortical cysts (HP:0000803) | 2.18910657 |
| 73 | Abnormality of the labia minora (HP:0012880) | 2.18580806 |
| 74 | Abnormality of vitamin B metabolism (HP:0004340) | 2.17793701 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.17705678 |
| 76 | Reticulocytopenia (HP:0001896) | 2.16536171 |
| 77 | Abnormality of macrophages (HP:0004311) | 2.14950383 |
| 78 | Increased serum pyruvate (HP:0003542) | 2.14192290 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12980530 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.12672801 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11861237 |
| 82 | X-linked dominant inheritance (HP:0001423) | 2.11277800 |
| 83 | Meningitis (HP:0001287) | 2.11250567 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09244189 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09180841 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.09180841 |
| 87 | Recurrent viral infections (HP:0004429) | 2.07934925 |
| 88 | Abnormality of T cells (HP:0002843) | 2.07921402 |
| 89 | Neutropenia (HP:0001875) | 2.06049051 |
| 90 | Recurrent skin infections (HP:0001581) | 2.04767029 |
| 91 | Abnormality of the intrinsic pathway (HP:0010989) | 2.04651062 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.04012966 |
| 93 | Purpura (HP:0000979) | 2.03646779 |
| 94 | Increased CSF lactate (HP:0002490) | 2.02977538 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02637727 |
| 96 | IgG deficiency (HP:0004315) | 2.02185834 |
| 97 | Symptomatic seizures (HP:0011145) | 2.01950310 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.99206103 |
| 99 | Hyperbilirubinemia (HP:0002904) | 1.99105368 |
| 100 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.99071690 |
| 101 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.98690371 |
| 102 | Male pseudohermaphroditism (HP:0000037) | 1.97926727 |
| 103 | Microcytic anemia (HP:0001935) | 1.97252421 |
| 104 | Vasculitis (HP:0002633) | 1.96747226 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 1.95977577 |
| 106 | Hyperphosphaturia (HP:0003109) | 1.95920136 |
| 107 | Lactic acidosis (HP:0003128) | 1.95678333 |
| 108 | Orchitis (HP:0100796) | 1.95181605 |
| 109 | Mediastinal lymphadenopathy (HP:0100721) | 1.95051439 |
| 110 | Abnormality of the renal cortex (HP:0011035) | 1.94764011 |
| 111 | Encephalitis (HP:0002383) | 1.94298185 |
| 112 | Abnormality of the renal medulla (HP:0100957) | 1.93976436 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.93759774 |
| 114 | Abnormal platelet function (HP:0011869) | 1.93759774 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 1.93530252 |
| 116 | Glycosuria (HP:0003076) | 1.93530252 |
| 117 | Sclerocornea (HP:0000647) | 1.93442890 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.92824903 |
| 119 | Nausea (HP:0002018) | 1.92375685 |
| 120 | Intestinal atresia (HP:0011100) | 1.91725492 |
| 121 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91653335 |
| 122 | Poor head control (HP:0002421) | 1.91611277 |
| 123 | Renal Fanconi syndrome (HP:0001994) | 1.90721715 |
| 124 | Abnormality of the prostate (HP:0008775) | 1.90334700 |
| 125 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90089136 |
| 126 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89095094 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.89086758 |
| 128 | CNS demyelination (HP:0007305) | 1.87861436 |
| 129 | Lipid accumulation in hepatocytes (HP:0006561) | 1.87825279 |
| 130 | Cerebral palsy (HP:0100021) | 1.87602295 |
| 131 | Large for gestational age (HP:0001520) | 1.86708786 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85688337 |
| 133 | Genital tract atresia (HP:0001827) | 1.85586466 |
| 134 | Hypoproteinemia (HP:0003075) | 1.85123539 |
| 135 | Proximal tubulopathy (HP:0000114) | 1.84856263 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.84420491 |
| 137 | Abnormality of glycolysis (HP:0004366) | 1.84280329 |
| 138 | Myokymia (HP:0002411) | 1.83732164 |
| 139 | Pancytopenia (HP:0001876) | 1.83731538 |
| 140 | Recurrent fungal infections (HP:0002841) | 1.83638438 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82674890 |
| 142 | Acute encephalopathy (HP:0006846) | 1.82633321 |
| 143 | Lymphopenia (HP:0001888) | 1.82610400 |
| 144 | Ketoacidosis (HP:0001993) | 1.80877099 |
| 145 | Gingival bleeding (HP:0000225) | 1.80506464 |
| 146 | Increased serum lactate (HP:0002151) | 1.80179312 |
| 147 | Periodontitis (HP:0000704) | 1.79347090 |
| 148 | Respiratory difficulties (HP:0002880) | 1.77923567 |
| 149 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77767561 |
| 150 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77007423 |
| 151 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.77002662 |
| 152 | Joint hemorrhage (HP:0005261) | 1.76673669 |
| 153 | Vaginal atresia (HP:0000148) | 1.76115147 |
| 154 | Macrocytic anemia (HP:0001972) | 1.76016374 |
| 155 | Hyperglycinemia (HP:0002154) | 1.75676678 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.73470308 |
| 157 | Delayed gross motor development (HP:0002194) | 1.70684356 |
| 158 | Megaloblastic anemia (HP:0001889) | 1.69919980 |
| 159 | Furrowed tongue (HP:0000221) | 1.69632552 |
| 160 | Type II lissencephaly (HP:0007260) | 1.66826649 |
| 161 | Anencephaly (HP:0002323) | 1.63735019 |
| 162 | Blindness (HP:0000618) | 1.63334119 |
| 163 | Short tibia (HP:0005736) | 1.60840428 |
| 164 | Abnormality of vitamin metabolism (HP:0100508) | 1.57826876 |
| 165 | Neuroendocrine neoplasm (HP:0100634) | 1.57574895 |
| 166 | Hypomagnesemia (HP:0002917) | 1.56181783 |
| 167 | EEG with generalized epileptiform discharges (HP:0011198) | 1.52331104 |
| 168 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.52209690 |
| 169 | Cystic liver disease (HP:0006706) | 1.52035579 |
| 170 | Pendular nystagmus (HP:0012043) | 1.51979623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.35228030 |
| 2 | FLT3 | 3.11396980 |
| 3 | FRK | 3.11047439 |
| 4 | KIT | 2.93836676 |
| 5 | TEC | 2.84707402 |
| 6 | TRIM28 | 2.73175388 |
| 7 | WNK3 | 2.48788109 |
| 8 | NME2 | 2.46761040 |
| 9 | MAP3K12 | 2.42736895 |
| 10 | MAP4K1 | 2.32011500 |
| 11 | TXK | 2.25359342 |
| 12 | BCKDK | 2.24757601 |
| 13 | IRAK4 | 2.22763925 |
| 14 | MAP4K2 | 2.21673190 |
| 15 | BTK | 2.18101482 |
| 16 | TNIK | 2.11289128 |
| 17 | IRAK3 | 2.07837285 |
| 18 | MAP3K14 | 2.04823813 |
| 19 | BLK | 1.96518194 |
| 20 | PIM2 | 1.96157804 |
| 21 | NME1 | 1.92535318 |
| 22 | MUSK | 1.85808100 |
| 23 | PNCK | 1.79809759 |
| 24 | TBK1 | 1.77735015 |
| 25 | TSSK6 | 1.71671278 |
| 26 | ZAP70 | 1.70719628 |
| 27 | CASK | 1.69568194 |
| 28 | CDK8 | 1.65023236 |
| 29 | EIF2AK3 | 1.57684660 |
| 30 | IKBKE | 1.56561934 |
| 31 | PLK3 | 1.55370410 |
| 32 | ADRBK2 | 1.53107638 |
| 33 | PDK2 | 1.52812467 |
| 34 | PLK4 | 1.52599928 |
| 35 | NLK | 1.51592149 |
| 36 | MAP3K4 | 1.50111910 |
| 37 | VRK1 | 1.50081587 |
| 38 | ERN1 | 1.48363893 |
| 39 | JAK3 | 1.45785419 |
| 40 | SYK | 1.44983551 |
| 41 | TAOK3 | 1.44900159 |
| 42 | BCR | 1.38710077 |
| 43 | PLK2 | 1.38177517 |
| 44 | PASK | 1.37529251 |
| 45 | MARK1 | 1.37401195 |
| 46 | TGFBR1 | 1.33607103 |
| 47 | PIK3CG | 1.32396437 |
| 48 | MAPK13 | 1.31705598 |
| 49 | TGFBR2 | 1.31695069 |
| 50 | NEK1 | 1.30564637 |
| 51 | MATK | 1.28977591 |
| 52 | DYRK2 | 1.28449406 |
| 53 | IKBKB | 1.28254164 |
| 54 | TYK2 | 1.27380760 |
| 55 | CSF1R | 1.25972652 |
| 56 | CSNK1G1 | 1.24696139 |
| 57 | LIMK1 | 1.24540891 |
| 58 | PHKG1 | 1.23146972 |
| 59 | PHKG2 | 1.23146972 |
| 60 | BRSK2 | 1.22546347 |
| 61 | CSNK1G3 | 1.19777228 |
| 62 | LYN | 1.18042884 |
| 63 | MYLK | 1.17888646 |
| 64 | CSNK1G2 | 1.17379852 |
| 65 | PAK3 | 1.15140295 |
| 66 | NUAK1 | 1.14425187 |
| 67 | STK39 | 1.14211513 |
| 68 | MST4 | 1.10927389 |
| 69 | SIK3 | 1.08035636 |
| 70 | ACVR1B | 1.08034313 |
| 71 | CAMKK2 | 1.07883319 |
| 72 | VRK2 | 1.06935666 |
| 73 | INSRR | 1.06595468 |
| 74 | OXSR1 | 1.06259119 |
| 75 | PBK | 1.05064047 |
| 76 | KDR | 1.03546924 |
| 77 | CCNB1 | 1.01919454 |
| 78 | RPS6KA4 | 1.01351524 |
| 79 | WNK4 | 0.99909966 |
| 80 | PRKCG | 0.97529139 |
| 81 | PRKCE | 0.95758601 |
| 82 | TIE1 | 0.95141108 |
| 83 | MAP2K6 | 0.93105306 |
| 84 | TNK2 | 0.92812246 |
| 85 | PLK1 | 0.92744128 |
| 86 | WEE1 | 0.91428389 |
| 87 | MAP2K3 | 0.91005258 |
| 88 | CDC7 | 0.88736502 |
| 89 | TTK | 0.86481577 |
| 90 | STK38L | 0.86217989 |
| 91 | MAPK15 | 0.85336221 |
| 92 | EIF2AK1 | 0.84893902 |
| 93 | CDK19 | 0.84860771 |
| 94 | RIPK4 | 0.84186508 |
| 95 | ITK | 0.82490886 |
| 96 | CSNK1A1L | 0.81775023 |
| 97 | MINK1 | 0.80869269 |
| 98 | ZAK | 0.79675006 |
| 99 | DYRK3 | 0.78268817 |
| 100 | NTRK3 | 0.77573916 |
| 101 | LCK | 0.77531258 |
| 102 | PIM1 | 0.73641802 |
| 103 | EIF2AK2 | 0.73375811 |
| 104 | YES1 | 0.73242455 |
| 105 | CHUK | 0.71806343 |
| 106 | MAPKAPK5 | 0.69657688 |
| 107 | IRAK1 | 0.69435611 |
| 108 | NEK9 | 0.67827501 |
| 109 | ERBB4 | 0.67278256 |
| 110 | TLK1 | 0.65869287 |
| 111 | BMPR2 | 0.65416290 |
| 112 | ERBB3 | 0.64674346 |
| 113 | HIPK2 | 0.63333063 |
| 114 | PRKCI | 0.62891134 |
| 115 | TAF1 | 0.62599981 |
| 116 | MKNK1 | 0.62338297 |
| 117 | STK24 | 0.60276480 |
| 118 | SRPK1 | 0.59948265 |
| 119 | RPS6KB2 | 0.58793295 |
| 120 | CAMK2A | 0.57953081 |
| 121 | ADRBK1 | 0.57789016 |
| 122 | CAMK2D | 0.57244572 |
| 123 | OBSCN | 0.55368048 |
| 124 | STK3 | 0.55017507 |
| 125 | CSNK2A2 | 0.53140522 |
| 126 | BMPR1B | 0.52212367 |
| 127 | MAPK4 | 0.51611459 |
| 128 | ATR | 0.51564823 |
| 129 | ILK | 0.50788763 |
| 130 | BUB1 | 0.50646695 |
| 131 | CSNK1A1 | 0.48960683 |
| 132 | CSNK1E | 0.48524436 |
| 133 | FGFR2 | 0.48435697 |
| 134 | PINK1 | 0.47698685 |
| 135 | BRSK1 | 0.46800612 |
| 136 | CSNK2A1 | 0.46755324 |
| 137 | GRK7 | 0.46454546 |
| 138 | RPS6KA6 | 0.45938120 |
| 139 | CDK7 | 0.45582854 |
| 140 | CAMK2G | 0.45157571 |
| 141 | RPS6KB1 | 0.44809279 |
| 142 | MAP3K3 | 0.44356588 |
| 143 | TRPM7 | 0.43339651 |
| 144 | ARAF | 0.43330301 |
| 145 | PRKACA | 0.43033819 |
| 146 | ABL2 | 0.42604062 |
| 147 | CLK1 | 0.41254492 |
| 148 | GRK1 | 0.41023483 |
| 149 | MKNK2 | 0.40872334 |
| 150 | FES | 0.40707700 |
| 151 | MAPKAPK3 | 0.40494937 |
| 152 | AURKB | 0.40255822 |
| 153 | MAPK11 | 0.39704699 |
| 154 | DAPK1 | 0.39306110 |
| 155 | MAP2K7 | 0.38956538 |
| 156 | UHMK1 | 0.38852892 |
| 157 | PRKCD | 0.38824335 |
| 158 | CDK3 | 0.38004791 |
| 159 | CAMK1 | 0.37319640 |
| 160 | RPS6KA5 | 0.37252786 |
| 161 | CHEK2 | 0.36845060 |
| 162 | TESK1 | 0.36085266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.84559481 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.04408157 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.73561101 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.55919185 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34383842 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.18473366 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.00209338 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.91969584 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90757698 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.87198620 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.84855424 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79037308 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.72845251 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71379530 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71359761 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70695110 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69033833 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.66335579 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64636409 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52007364 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50510834 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50445918 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50134940 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.49928290 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49148936 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48914067 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48627490 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48490610 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.47807838 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46864927 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46049078 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.45215217 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43252597 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.39543927 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37445372 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37050337 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35164379 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33820619 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30172496 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.27573154 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23496522 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22944097 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18723515 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18250110 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16270916 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15810983 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15172517 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15116789 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12260184 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10038510 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09869536 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08547017 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08034535 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07214978 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.05974290 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.04791341 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.04666541 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02052990 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.01304236 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00271381 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96625282 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96481645 |
| 63 | RNA transport_Homo sapiens_hsa03013 | 0.95932512 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.95731487 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94108554 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92619958 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.92574488 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91122981 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90295687 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89993649 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88902456 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87520268 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86289791 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86231162 |
| 75 | * Folate biosynthesis_Homo sapiens_hsa00790 | 0.86076943 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85675683 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85623031 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.84779601 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82710114 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82694916 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80811553 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80318397 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79823990 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.78936832 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76293031 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73710942 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73085841 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72089077 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71446908 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71352139 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.70118409 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.68904367 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.68549687 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66982760 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.66943324 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66420227 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64785381 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64622259 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64128250 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63574132 |
| 101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63324942 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63163205 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62948721 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62933305 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61955320 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61771676 |
| 107 | Insulin secretion_Homo sapiens_hsa04911 | 0.61697147 |
| 108 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.61516251 |
| 109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60957362 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58964259 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57308731 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56544450 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55496699 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55358582 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54721534 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54407053 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54346339 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.54212897 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53596071 |
| 120 | Taste transduction_Homo sapiens_hsa04742 | 0.53061120 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52369023 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52346242 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.52205039 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51945651 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50761081 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50757170 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50344846 |
| 128 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50204718 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50203428 |
| 130 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48299470 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47826210 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46746381 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.46671613 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46475066 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46075482 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45991561 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43375173 |
| 138 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43297751 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41641572 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40294199 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39313658 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33986556 |
| 143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33426962 |
| 144 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33192213 |
| 145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32508740 |

